Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.

By B. Maron, Iacopo Olivotto, P. Spirito, S. Casey, P. Bellone, T. E. Gohman, K. Graham, David Burton, F. Cecchi. Circulation, 2000

811 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/72259761a44d5168b20171fa22ea42af68286acc

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. P. Spirito
2. B. Maron
3. C. Seidman
4. Judith Hochman
5. Douglas P. Zipes
6. M. Maron

Citations in the corpus

• Task Force on Sudden Cardiac Death of the European Society of Cardiology. (2001, background): “HCM is a relatively common cardiac disorder (adult prevalence about 1:500) in which sudden unexpected death is the most devastating component, occurring throughout life, but particularly in young, often asymptomatic patients([295]).”
• Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy (2001, neutral): “Sudden, unexpected 7 (16) 5 (16) 1 (3) 13 (12)”
• American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G (2003, background): “Indeed, ventricular arrhythmias are an important clinical feature in adults with HCM.”